ArticleNeuro-oncology2017

Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.

Amanda E D Van Swearingen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.